BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹14,334 Cr | ₹15,359 Cr | ₹8,511 Cr | ₹3,828 Cr | ₹4,210 Cr |
What is the latest Total Current Liabilities ratio of BIOCON ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹14,334 Cr |
| Mar2024 | ₹15,359 Cr |
| Mar2023 | ₹8,511 Cr |
| Mar2022 | ₹3,828 Cr |
| Mar2021 | ₹4,210 Cr |
How is Total Current Liabilities of BIOCON Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14,334 Cr | -6.67 | |
| Mar2024 | ₹15,359 Cr | 80.46 | |
| Mar2023 | ₹8,511 Cr | 122.33 | |
| Mar2022 | ₹3,828 Cr | -9.08 | |
| Mar2021 | ₹4,210 Cr | - | |
Compare Total Current Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹59,997.6 Cr | 1.5% | -6.4% | -5.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 1.5% |
-6.4% |
-5.8% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses